![](/img/cover-not-exists.png)
A PHASE 3, 26-WEEK, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF AC-1204 IN MILD-TO-MODERATE ALZHEIMER'S DISEASE: STUDY DESIGN AND PROGRESS
Farlow, Martin R., Gold, Michael, Henderson, Samuel, Greer, Sabrina, Vogel, Janet, Shenkin, AaronVolume:
12
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2016.06.2091
Date:
July, 2016
File:
PDF, 48 KB
english, 2016